Fulgent Genetics Inc (FLGT) has a current Price-to-Book (P/B) ratio of 0.70. Compared to its 3-year average P/B ratio of 0.63, the current P/B ratio is approximately 11.89% higher. Relative to its 5-year average P/B ratio of 1.17, the current P/B ratio is about -40.12% higher. Fulgent Genetics Inc (FLGT) has a Forward Free Cash Flow (FCF) yield of approximately -2.51%. Compared to its 3-year average FCF yield of -0.00%, the current FCF yield is approximately 97949.15% lower. Relative to its 5-year average FCF yield of 9.21%, the current FCF yield is about -127.23% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for FLGT competitors is 1.36, providing a benchmark for relative valuation. Fulgent Genetics Inc Corp (FLGT.O) exhibits a P/S ratio of 2.27, which is 67.11% above the industry average. Given its robust revenue growth of 9.34%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of FLGT increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of FLGT in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is FLGT currently overvalued or undervalued?

What is Fulgent Genetics Inc (FLGT) fair value?

FLGT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Fulgent Genetics Inc (FLGT) is between 11.98 to 22.77 according to relative valuation method.

How does FLGT's valuation metrics compare to the industry average?

The average P/S ratio for FLGT's competitors is 1.36, providing a benchmark for relative valuation. Fulgent Genetics Inc Corp (FLGT) exhibits a P/S ratio of 2.27, which is 67.11% above the industry average. Given its robust revenue growth of 9.34%, this premium appears unsustainable.

What is the current P/B ratio for Fulgent Genetics Inc (FLGT) as of Mar 04 2026?

As of Mar 04 2026, Fulgent Genetics Inc (FLGT) has a P/B ratio of 0.70. This indicates that the market values FLGT at 0.70 times its book value.

What is the current FCF Yield for Fulgent Genetics Inc (FLGT) as of Mar 04 2026?

As of Mar 04 2026, Fulgent Genetics Inc (FLGT) has a FCF Yield of -2.51%. This means that for every dollar of Fulgent Genetics Inc's market capitalization, the company generates -2.51 cents in free cash flow.

What is the current Forward P/E ratio for Fulgent Genetics Inc (FLGT) as of Mar 04 2026?

As of Mar 04 2026, Fulgent Genetics Inc (FLGT) has a Forward P/E ratio of -128.21. This means the market is willing to pay $-128.21 for every dollar of Fulgent Genetics Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Fulgent Genetics Inc (FLGT) as of Mar 04 2026?

As of Mar 04 2026, Fulgent Genetics Inc (FLGT) has a Forward P/S ratio of 2.27. This means the market is valuing FLGT at $2.27 for every dollar of expected revenue over the next 12 months.

FLGT Valuation